The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Jan 08, 2025•over 1 year ago
Contract Type
partnership
MarlboroughBiotechnologyHealth CareMedical
Description
Lifeward Ltd. announced the closing of a registered direct offering priced at-the-market under Nasdaq rules, with the gross proceeds to the company reaching approximately $5.0 million. The net proceeds are intended to be used for continuing commercial efforts, working capital, and general corporate purposes.
Company Information
Company
Lifeward
Location
Marlborough, Massachusetts, United States
About
Lifeward is a medical device manufacturer specializing in mobility-related solutions. Their products include the ReWalk Personal Exoskeleton and AlterG Anti-Gravity Systems. Lifeward is dedicated to helping individuals with physical limitations regain mobility. The company is involved in groundbreaking technologies to enhance treatment methodologies.